Results 31 to 40 of about 345,011 (339)

RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children

open access: yesBMC Cancer, 2023
Background Neuroblastoma, a neuroendocrine tumor originating from the sympathetic ganglia, is one of the most common malignancies in childhood. RTEL1 is critical in many fundamental cellular processes, such as DNA replication, DNA damage repair, genomic ...
Ting Zhang   +5 more
doaj   +1 more source

Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells [PDF]

open access: yes, 2013
This is the author's accepted manuscript. The final published article is available from the link below. Note: In this manuscript as well as in the original published version of this article the word "Polyphenon" was incorrectly spelled in the title as ...
Adrian J. Thrasher   +14 more
core   +2 more sources

Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

open access: yesNature Communications, 2021
Childhood neuroblastoma has a remarkable variability in outcome. Age at diagnosis is one of the most important prognostic factors, with children less than 1 year old having favorable outcomes. Here we study single-cell and single-nuclei transcriptomes of
O. Bedoya-Reina   +15 more
semanticscholar   +1 more source

Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells [PDF]

open access: yes, 2015
This research was originally published in Journal of Biological Chemistry. Olesya Chayka, Cosimo Walter D’Acunto, Odette Middleton, Maryam Arab, and Arturo Sala.
Arab, M   +4 more
core   +1 more source

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma

open access: yesJournal of Clinical Investigation, 2018
High-risk neuroblastoma is a devastating malignancy with very limited therapeutic options. Here, we identify withaferin A (WA) as a natural ferroptosis-inducing agent in neuroblastoma, which acts through a novel double-edged mechanism.
Behrouz Hassannia   +24 more
semanticscholar   +1 more source

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma

open access: yesNature Communications, 2020
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA).
K. Helmsauer   +28 more
semanticscholar   +1 more source

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.

open access: yesPLoS ONE, 2021
Investigation of the mechanisms responsible for aggressive neuroblastoma and its poor prognosis is critical to identify novel therapeutic targets and improve survival.
Laura V Bownes   +11 more
doaj   +1 more source

Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells [PDF]

open access: yes, 2009
BACKGROUND: Chemoresistance acquisition may influence cancer cell biology. Here, bioinformatics analysis of gene expression data was used to identify chemoresistance-associated changes in neuroblastoma biology.
Barth, Susanne   +10 more
core   +6 more sources

Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell

open access: yesScience Advances, 2021
Comparisons of neuroblastoma cells and relevant normal adrenal cells reveal a uniform cell state that characterizes neuroblastoma. Neuroblastoma is a childhood cancer that resembles developmental stages of the neural crest.
Gerda Kildisiute   +38 more
semanticscholar   +1 more source

Anesthetic management of an infant with giant abdominal neuroblastoma

open access: yesBrazilian Journal of Anesthesiology, 2017
Neuroblastoma is the most common, non-central nervous system tumor of childhood. It has the potential to synthesize catecholamines. However, the presences of hypertension are uncommon.
Manuel Ángel Gómez-Ríos   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy